| Year |
Citation |
Score |
| 2022 |
Doonan BP, Amria S, Bethard JR, Banik NL, Hathaway-Schrader JD, Haque A. Peptide Modification Diminishes HLA Class II-restricted CD4 T Cell Recognition of Prostate Cancer Cells. International Journal of Molecular Sciences. 23. PMID 36499557 DOI: 10.3390/ijms232315234 |
0.304 |
|
| 2022 |
Hathaway-Schrader JD, Norton D, Hastings K, Doonan BP, Fritz ST, Bethard JR, Blum JS, Haque A. GILT Expression in Human Melanoma Cells Enhances Generation of Antigenic Peptides for HLA Class II-Mediated Immune Recognition. International Journal of Molecular Sciences. 23. PMID 35162988 DOI: 10.3390/ijms23031066 |
0.463 |
|
| 2020 |
Zhao D, Hajiaghamohseni LM, Liu X, Szulc ZM, Bai A, Bielawska A, Norris JS, Reddy SV, Hannun YA, Haque A. Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis. Cytokine. 135: 155219. PMID 32738771 DOI: 10.1016/J.Cyto.2020.155219 |
0.537 |
|
| 2020 |
Polcyn R, Capone M, Matzelle D, Hossain A, Chandran R, Banik NL, Haque A. Enolase inhibition alters metabolic hormones and inflammatory factors to promote neuroprotection in spinal cord injury. Neurochemistry International. 104788. PMID 32650031 DOI: 10.1016/J.Neuint.2020.104788 |
0.411 |
|
| 2020 |
Haque A, Samantaray S, Knaryan VH, Capone M, Hossain A, Matzelle D, Chandran R, Shields DC, Farrand AQ, Boger HA, Banik NL. Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease. Experimental Neurology. 113315. PMID 32302678 DOI: 10.1016/J.Expneurol.2020.113315 |
0.45 |
|
| 2019 |
Polcyn R, Capone M, Matzelle D, Lueking B, Walker A, Kau E, Haque A, Banik N. Cytokine/chemokine dysregulation in progressive MS patient is apparent and can be modulated by calpain inhibition. Metabolic Brain Disease. PMID 31853829 DOI: 10.1007/S11011-019-00521-1 |
0.404 |
|
| 2019 |
Ethiraj P, Sambandam Y, Hathaway-Schrader JD, Haque A, Novince CM, Reddy SV. RANKL triggers resistance to TRAIL-induced cell death in oral squamous cell carcinoma. Journal of Cellular Physiology. PMID 31309556 DOI: 10.1002/Jcp.29086 |
0.461 |
|
| 2018 |
Johnson BM, Radwan FFY, Hossain A, Doonan BP, Hathaway-Schrader JD, God JM, Voelkel-Johnson CV, Banik NL, Reddy SV, Haque A. Endoplasmic reticulum stress, autophagic and apoptotic cell death, and immune activation by a natural triterpenoid in human prostate cancer cells. Journal of Cellular Biochemistry. PMID 30378157 DOI: 10.1002/Jcb.27913 |
0.457 |
|
| 2018 |
Chandran R, Capone M, Matzelle D, Polcyn R, Kau E, Haque A, Banik NL. Distinct Cytokine and Chemokine Expression in Plasma and Calpeptin-Treated PBMCs of a Relapsing-Remitting Multiple Sclerosis Patient: A Case Report. Neurochemical Research. PMID 30291537 DOI: 10.1007/S11064-018-2655-Z |
0.304 |
|
| 2018 |
Haque A, Polcyn R, Matzelle D, Banik NL. New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection. Brain Sciences. 8. PMID 29463007 DOI: 10.3390/Brainsci8020033 |
0.418 |
|
| 2017 |
Bryant JM, Bouchard M, Haque A. Anticancer Activity of Ganoderic Acid DM: Current Status and Future Perspective. Journal of Clinical & Cellular Immunology. 8. PMID 29399381 DOI: 10.4172/2155-9899.1000535 |
0.425 |
|
| 2017 |
Trager NNM, Butler JT, Harmon J, Mount J, Podbielska M, Haque A, Banik NL, Beeson CC. A Novel Aza-MBP Altered Peptide Ligand for the Treatment of Experimental Autoimmune Encephalomyelitis. Molecular Neurobiology. PMID 28889362 DOI: 10.1007/S12035-017-0739-4 |
0.482 |
|
| 2017 |
Hathaway-Schrader JD, Doonan BP, Hossain A, Radwan FFY, Zhang L, Haque A. Autophagy-Dependent Crosstalk between GILT and PAX-3 Influences Radiation Sensitivity of Human Melanoma Cells. Journal of Cellular Biochemistry. PMID 28857256 DOI: 10.1002/Jcb.26383 |
0.477 |
|
| 2017 |
Haque A, Capone M, Matzelle D, Cox A, Banik NL. Targeting Enolase in Reducing Secondary Damage in Acute Spinal Cord Injury in Rats. Neurochemical Research. PMID 28508172 DOI: 10.1007/S11064-017-2291-Z |
0.414 |
|
| 2016 |
God JM, Haque A. Multiple Defects Impair the HLA Class II Antigen Presentation Capacity of Burkitt Lymphoma. Journal of Clinical & Cellular Immunology. 7. PMID 27747135 DOI: 10.4172/2155-9899.1000E119 |
0.448 |
|
| 2016 |
Capone M, Bryant JM, Sutkowski N, Haque A. Fc Receptor-Like Proteins in Pathophysiology of B-cell Disorder. Journal of Clinical & Cellular Immunology. 7. PMID 27446638 DOI: 10.4172/2155-9899.1000427 |
0.409 |
|
| 2016 |
Haque A, Ray SK, Cox A, Banik NL. Neuron specific enolase: a promising therapeutic target in acute spinal cord injury. Metabolic Brain Disease. PMID 26847611 DOI: 10.1007/S11011-016-9801-6 |
0.419 |
|
| 2015 |
Doonan BP, Haque A. Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design. Journal of Clinical & Cellular Immunology. 6. PMID 26807308 DOI: 10.4172/2155-9899.1000351 |
0.479 |
|
| 2015 |
Chakrabarti M, Das A, Samantaray S, Smith JA, Banik NL, Haque A, Ray SK. Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury. Reviews in the Neurosciences. PMID 26461840 DOI: 10.1515/Revneuro-2015-0032 |
0.408 |
|
| 2015 |
Samantaray S, Knaryan VH, Shields DC, Cox AA, Haque A, Banik NL. Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice. Molecular Neurobiology. 52: 1054-66. PMID 26108182 DOI: 10.1007/S12035-015-9255-6 |
0.436 |
|
| 2015 |
Sambandam Y, Sakamuri S, Balasubramanian S, Haque A. RANK Ligand Modulation of Autophagy in Oral Squamous Cell Carcinoma Tumor Cells. Journal of Cellular Biochemistry. PMID 26095774 DOI: 10.1002/Jcb.25255 |
0.499 |
|
| 2015 |
God JM, Cameron C, Figueroa J, Amria S, Hossain A, Kempkes B, Bornkamm GW, Stuart RK, Blum JS, Haque A. Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors. Journal of Immunology (Baltimore, Md. : 1950). 194: 1434-45. PMID 25595783 DOI: 10.4049/Jimmunol.1402382 |
0.527 |
|
| 2015 |
Radwan FF, Hossain A, God JM, Leaphart N, Elvington M, Nagarkatti M, Tomlinson S, Haque A. Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid. Journal of Cellular Biochemistry. 116: 102-14. PMID 25142864 DOI: 10.1002/Jcb.24946 |
0.502 |
|
| 2014 |
Chakrabarti M, Haque A, Banik NL, Nagarkatti P, Nagarkatti M, Ray SK. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration. Brain Research Bulletin. 109: 22-31. PMID 25245209 DOI: 10.1016/J.Brainresbull.2014.09.004 |
0.409 |
|
| 2014 |
God JM, Zhao D, Cameron CA, Amria S, Bethard JR, Haque A. Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition. Immunology. 142: 492-505. PMID 24628049 DOI: 10.1111/Imm.12281 |
0.528 |
|
| 2014 |
Sambandam Y, Townsend MT, Pierce JJ, Lipman CM, Haque A, Bateman TA, Reddy SV. Microgravity control of autophagy modulates osteoclastogenesis. Bone. 61: 125-31. PMID 24463210 DOI: 10.1016/J.Bone.2014.01.004 |
0.423 |
|
| 2014 |
Trager N, Smith A, Wallace Iv G, Azuma M, Inoue J, Beeson C, Haque A, Banik NL. Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis. Journal of Neurochemistry. 130: 268-79. PMID 24447070 DOI: 10.1111/Jnc.12659 |
0.479 |
|
| 2013 |
Trager N, Butler JT, Haque A, Ray SK, Beeson C, Banik NL. The Involvement of Calpain in CD4(+) T Helper Cell Bias in Multple Sclerosis. Journal of Clinical & Cellular Immunology. 4: 1000153. PMID 24707444 DOI: 10.4172/2155-9899.1000153 |
0.478 |
|
| 2013 |
Doonan B, Hossain A, Radwan F, Haque A. Abstract 1653: Regulation of autophagy and apoptosis by a natural triterpenoid in diffuse large B-cell lymphoma. Cancer Research. 73: 1653-1653. DOI: 10.1158/1538-7445.Am2013-1653 |
0.47 |
|
| 2012 |
Hossain A, Radwan FF, Doonan BP, God JM, Zhang L, Bell PD, Haque A. A possible cross-talk between autophagy and apoptosis in generating an immune response in melanoma. Apoptosis : An International Journal On Programmed Cell Death. 17: 1066-78. PMID 22847295 DOI: 10.1007/S10495-012-0745-Y |
0.515 |
|
| 2012 |
Radwan FF, Zhang L, Hossain A, Doonan BP, God JM, Haque A. Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol. Leukemia & Lymphoma. 53: 305-14. PMID 21854084 DOI: 10.3109/10428194.2011.615423 |
0.542 |
|
| 2012 |
Haque A, Radwan FFY, Hossain A, God JM. Abstract 5641: Dual roles for ganoderic acid A in inducing apoptosis and enhancing HLA class II presentation in leukemia and lymphoma cells Cancer Research. 72: 5641-5641. DOI: 10.1158/1538-7445.Am2012-5641 |
0.52 |
|
| 2011 |
Hathaway JD, Haque A. Insights into the Role of PAX-3 in the Development of Melanocytes and Melanoma. The Open Cancer Journal. 4: 1-6. PMID 24790680 DOI: 10.2174/1874079001104010001 |
0.303 |
|
| 2011 |
God JM, Haque A. Immune Evasion by B-cell Lymphoma. Journal of Clinical & Cellular Immunology. 2. PMID 23336086 DOI: 10.4172/2155-9899.1000E103 |
0.469 |
|
| 2011 |
Hossain A, God JM, Radwan FF, Amria S, Zhao D, Bethard JR, Haque A. HLA class II defects in Burkitt lymphoma: bryostatin-1-induced 17 kDa protein restores CD4+ T-cell recognition. Clinical & Developmental Immunology. 2011: 780839. PMID 22162713 DOI: 10.1155/2011/780839 |
0.522 |
|
| 2011 |
Zhao D, Amria S, Hossain A, Sundaram K, Komlosi P, Nagarkatti M, Haque A. Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1. Cellular Immunology. 271: 392-400. PMID 21903207 DOI: 10.1016/J.Cellimm.2011.08.007 |
0.545 |
|
| 2011 |
Haque A, Banik NL, Ray SK. Molecular alterations in glioblastoma: potential targets for immunotherapy. Progress in Molecular Biology and Translational Science. 98: 187-234. PMID 21199773 DOI: 10.1016/B978-0-12-385506-0.00005-3 |
0.436 |
|
| 2011 |
Smith AW, Doonan BP, Tyor WR, Abou-Fayssal N, Haque A, Banik NL. Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients. Journal of Neuroimmunology. 232: 179-85. PMID 21075457 DOI: 10.1016/J.Jneuroim.2010.09.030 |
0.451 |
|
| 2011 |
Haque A, Johnson BM, Doonan BP, Hossain A, Radwan FF. Abstract 5487: Anti-proliferative, apoptotic and immunological effects of ganoderic acid DM on prostate cancer cells Cancer Research. 71: 5487-5487. DOI: 10.1158/1538-7445.Am2011-5487 |
0.45 |
|
| 2010 |
Johnson BM, Doonan BP, Radwan FF, Haque A. Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer. The Open Prostate Cancer Journal. 3: 78-85. PMID 24790681 DOI: 10.2174/1876822901003010078 |
0.302 |
|
| 2010 |
Doonan BP, Haque A. HLA Class II Antigen Presentation in Prostate Cancer Cells: A Novel Approach to Prostate Tumor Immunotherapy. The Open Cancer Immunology Journal. 3: 1-7. PMID 24163711 DOI: 10.2174/1876401001003010001 |
0.494 |
|
| 2010 |
God JM, Haque A. Burkitt lymphoma: pathogenesis and immune evasion. Journal of Oncology. 2010. PMID 20953370 DOI: 10.1155/2010/516047 |
0.518 |
|
| 2010 |
Haque A, Norton D, Doonan B, Amria S. Abstract 4787: GILT regulates antigen processing and CD4+ T cell recognition of melanoma cells Cancer Research. 70: 4787-4787. DOI: 10.1158/1538-7445.Am10-4787 |
0.554 |
|
| 2009 |
Norton DL, Haque A. Insights into the Role of GILT in HLA Class II Antigen Processing and Presentation by Melanoma. Journal of Oncology. 2009: 142959. PMID 20016802 DOI: 10.1155/2009/142959 |
0.534 |
|
| 2008 |
Amria S, Hajiaghamohseni LM, Harbeson C, Zhao D, Goldstein O, Blum JS, Haque A. HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition. European Journal of Immunology. 38: 1961-70. PMID 18506881 DOI: 10.1002/Eji.200738100 |
0.494 |
|
| 2008 |
Goldstein OG, Hajiaghamohseni LM, Amria S, Sundaram K, Reddy SV, Haque A. Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma. Cancer Immunology, Immunotherapy : Cii. 57: 1461-70. PMID 18343923 DOI: 10.1007/S00262-008-0483-8 |
0.553 |
|
| 2008 |
Amria S, Cameron C, Stuart R, Haque A. Defects in HLA class II antigen presentation in B-cell lymphomas. Leukemia & Lymphoma. 49: 353-5. PMID 18231926 DOI: 10.1080/10428190701814305 |
0.471 |
|
| 2008 |
Younger AR, Amria S, Jeffrey WA, Mahdy AE, Goldstein OG, Norris JS, Haque A. HLA class II antigen presentation by prostate cancer cells. Prostate Cancer and Prostatic Diseases. 11: 334-41. PMID 17938645 DOI: 10.1038/Sj.Pcan.4501021 |
0.507 |
|
| 2007 |
Haque A, Hajiaghamohseni LM, Li P, Toomy K, Blum JS. Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells. Cellular Immunology. 249: 20-9. PMID 18067883 DOI: 10.1016/J.Cellimm.2007.10.005 |
0.469 |
|
| 2007 |
Imam SA, Guyton MK, Haque A, Vandenbark A, Tyor WR, Ray SK, Banik NL. Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. Journal of Neuroimmunology. 190: 139-45. PMID 17765980 DOI: 10.1016/J.Jneuroim.2007.07.016 |
0.404 |
|
| 2007 |
Haque A, Banik NL, Ray SK. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma. Neurochemical Research. 32: 2203-9. PMID 17676389 DOI: 10.1007/S11064-007-9420-Z |
0.423 |
|
| 2007 |
Haque A, Das A, Hajiaghamohseni LM, Younger A, Banik NL, Ray SK. Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells Cancer Immunology, Immunotherapy. 56: 615-625. PMID 16947022 DOI: 10.1007/S00262-006-0219-6 |
0.538 |
|
| 2007 |
Kasper LH, Haque A, Haque S. Regulatory mechanisms of the immune system in multiple sclerosis. T regulatory cells: Turned on to turn off Journal of Neurology. 254. DOI: 10.1007/S00415-007-1003-Z |
0.301 |
|
| 2004 |
O'Donnell PW, Haque A, Klemsz MJ, Kaplan MH, Blum JS. Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but CIITA-independent. Journal of Immunology (Baltimore, Md. : 1950). 173: 731-5. PMID 15240658 DOI: 10.4049/Jimmunol.173.2.731 |
0.442 |
|
| Show low-probability matches. |